Establishment of a Sensitive System for Analysis of Child-bearing Women Vaginal Microbiota
ESSACWVM
1 other identifier
observational
50
1 country
1
Brief Summary
The vaginal microbiota is an important biological barrier for host against pathogens or opportunistic pathogens. Undermining the balance of the vagina is closely related to infectious diseases and tumors. The vaginal microbiota of child-bearing women of age is dominated by Lactobacillus species, including major four species: Lactobacillus crispatus, Lactobacillus jensenii, Lactobacillus gasseri and Lactobacillus iners, followed by obligate anaerobes such as Gardnerella vaginalis, Atopobium vaginae, Mobiluncus curtisii, and Prevotella . Currently, There are almost 99% bacteria can not to be found with bacterial culture. Based on microscopy and conventional culture method to obtain vaginal microflora information have a variety of deviation. For this reason, The in-depth study of complex vaginal flora and the correct understanding of disease faces a serious obstacle. With the development of High-throughput sequencing technology, metagenomics can get all the composition and distribution of microorganisms from the sample which traditional knowledge may not be with microorganism culture method. Therefore, Re-evaluation of existing microflora diagnostic criteria for clinical diagnosis of the disease is necessary. In this study, the investigators use high-throughput sequencing technology to detect women of childbearing age vaginal microflora of metagenomic distribution. Including bacteria, fungi, viruses, protozoa, and other microorganisms. Based on the study results of metagenomic, the investigators want to re-cognition the"normal flora"of women of childbearing age ,and develop vaginal microflora microscopic evaluation of the integrity of the reference standard.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2016
CompletedFirst Posted
Study publicly available on registry
May 5, 2016
CompletedStudy Start
First participant enrolled
May 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedMarch 24, 2017
March 1, 2017
1.6 years
April 26, 2016
March 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The use of High-throughput sequencing to establishment a sensitive system of the composition of vaginal Microbiota of normal Child-bearing Women
From the date of first normal woman who entered the subject to a whole menstrual cycles ended up to one month
The use of High-throughput sequencing to comparison the composition of vaginal flora of normal women of childbearing age and women with vaginitis
From the date of one subjects entered to a whole menstrual cycles ended up to one month
Study Arms (2)
normal women
Composition of Viginal flora of Child-Bearing women in normal woman
vaginitis women
Women of childbearing age with vaginitis
Interventions
Use high-throughput sequencing technology to exam Composition of Viginal flora of Child-Bearing women in different menstrual cycle and type of Vaginitis
Eligibility Criteria
Child-bearing Woman
You may qualify if:
- Normal Child-bearing Women
You may not qualify if:
- Pregnancy women
- Lactating women
- Using antibiotics or vaginal topical application of antibiotics over a month
- Have sexual activity in 3 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Xian Jiaotong University
Xi'an, Shaanxi, 710061, China
Biospecimen
Vaginal secretions from Child-bearing Women
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yawen Wang, Ph.D
First Affiliated Hospital of Xian Jiaotong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2016
First Posted
May 5, 2016
Study Start
May 10, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2018
Last Updated
March 24, 2017
Record last verified: 2017-03